Matches in Nanopublications for { ?s ?p "[As Ubc9 is the sole E2-conjugating enzyme required for sumoylation, and, in particular, Ubc9 is upregulated in an increasing number of human malignancies, such as ovarian carcinoma, melanoma and lung adenocarcinoma, it is a potential target for cancer therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 11 of
11
with 100 items per page.
- NP446980.RAxpAg-8vbd13g10tQL63d_SNM9x29BEscPyum-yG2Yl4130_assertion description "[As Ubc9 is the sole E2-conjugating enzyme required for sumoylation, and, in particular, Ubc9 is upregulated in an increasing number of human malignancies, such as ovarian carcinoma, melanoma and lung adenocarcinoma, it is a potential target for cancer therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP446980.RAxpAg-8vbd13g10tQL63d_SNM9x29BEscPyum-yG2Yl4130_provenance.
- NP764734.RARVC-zfmYw2_L0FG-xnwO6JxzzhJBUI42iAo8_EfY3Bo130_assertion description "[As Ubc9 is the sole E2-conjugating enzyme required for sumoylation, and, in particular, Ubc9 is upregulated in an increasing number of human malignancies, such as ovarian carcinoma, melanoma and lung adenocarcinoma, it is a potential target for cancer therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP764734.RARVC-zfmYw2_L0FG-xnwO6JxzzhJBUI42iAo8_EfY3Bo130_provenance.
- NP764750.RA1hxRmezfK0Zuedzla0z2XverOdSEV3-ugKJG61LFOxA130_assertion description "[As Ubc9 is the sole E2-conjugating enzyme required for sumoylation, and, in particular, Ubc9 is upregulated in an increasing number of human malignancies, such as ovarian carcinoma, melanoma and lung adenocarcinoma, it is a potential target for cancer therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP764750.RA1hxRmezfK0Zuedzla0z2XverOdSEV3-ugKJG61LFOxA130_provenance.
- NP523378.RA07iaPTnTNHm_6nNkT2fJLPlKPktwLMvTXGG7LPMnOZk130_assertion description "[As Ubc9 is the sole E2-conjugating enzyme required for sumoylation, and, in particular, Ubc9 is upregulated in an increasing number of human malignancies, such as ovarian carcinoma, melanoma and lung adenocarcinoma, it is a potential target for cancer therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP523378.RA07iaPTnTNHm_6nNkT2fJLPlKPktwLMvTXGG7LPMnOZk130_provenance.
- NP523377.RAbUT6LOWGcs9cT9xt7qUhWE2JV7NPFZbqjqF-v-_eL1k130_assertion description "[As Ubc9 is the sole E2-conjugating enzyme required for sumoylation, and, in particular, Ubc9 is upregulated in an increasing number of human malignancies, such as ovarian carcinoma, melanoma and lung adenocarcinoma, it is a potential target for cancer therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP523377.RAbUT6LOWGcs9cT9xt7qUhWE2JV7NPFZbqjqF-v-_eL1k130_provenance.
- assertion description "[As Ubc9 is the sole E2-conjugating enzyme required for sumoylation, and, in particular, Ubc9 is upregulated in an increasing number of human malignancies, such as ovarian carcinoma, melanoma and lung adenocarcinoma, it is a potential target for cancer therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[As Ubc9 is the sole E2-conjugating enzyme required for sumoylation, and, in particular, Ubc9 is upregulated in an increasing number of human malignancies, such as ovarian carcinoma, melanoma and lung adenocarcinoma, it is a potential target for cancer therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[As Ubc9 is the sole E2-conjugating enzyme required for sumoylation, and, in particular, Ubc9 is upregulated in an increasing number of human malignancies, such as ovarian carcinoma, melanoma and lung adenocarcinoma, it is a potential target for cancer therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[As Ubc9 is the sole E2-conjugating enzyme required for sumoylation, and, in particular, Ubc9 is upregulated in an increasing number of human malignancies, such as ovarian carcinoma, melanoma and lung adenocarcinoma, it is a potential target for cancer therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP523379.RAP8UxSh-zkGra15e1rzhTjUaDZuz35vtgmh7X1sQFldw130_assertion description "[As Ubc9 is the sole E2-conjugating enzyme required for sumoylation, and, in particular, Ubc9 is upregulated in an increasing number of human malignancies, such as ovarian carcinoma, melanoma and lung adenocarcinoma, it is a potential target for cancer therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP523379.RAP8UxSh-zkGra15e1rzhTjUaDZuz35vtgmh7X1sQFldw130_provenance.
- NP764738.RArBuza4wVpaSvjh-3iD79bdvyZrKCwaRTsMP8y5CYfhI130_assertion description "[As Ubc9 is the sole E2-conjugating enzyme required for sumoylation, and, in particular, Ubc9 is upregulated in an increasing number of human malignancies, such as ovarian carcinoma, melanoma and lung adenocarcinoma, it is a potential target for cancer therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP764738.RArBuza4wVpaSvjh-3iD79bdvyZrKCwaRTsMP8y5CYfhI130_provenance.